Modification of tumour blood flow using the hypertensive agent, angiotensin II.

por Tozer, G. M., Shaffi, K. M.
Publicado 1993

The response of tumour vasculature to angiotensin II revealed by its systemic and local administration to 'tissue-isolated' tumours.

por Tozer, G. M., Shaffi, K. M.
Publicado 1995

The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma.

por Tozer, G. M., Lewis, S., Michalowski, A., Aber, V.
Publicado 1990

Use of horseradish peroxidase for gene-directed enzyme prodrug therapy with paracetamol

por Tupper, J, Tozer, G M, Dachs, G U
Publicado 2004

Gene delivery to hypoxic cells in vitro

por Dachs, G U, Coralli, C, Hart, S L, Tozer, G M
Publicado 2000

Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension.

por Tozer, G. M., Maxwell, R. J., Griffiths, J. R., Pham, P.
Publicado 1990

Characterisation of tumour blood flow using a 'tissue-isolated' preparation.

por Tozer, G. M., Shaffi, K. M., Prise, V. E., Cunningham, V. J.
Publicado 1994

Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide

por Parkins, C S, Holder, A L, Hill, S A, Chaplin, D J, Tozer, G M
Publicado 2000

Resistance to flow through tissue-isolated transplanted rat tumours located in two different sites.

por Sensky, P. L., Prise, V. E., Tozer, G. M., Shaffi, K. M., Hirst, D. G.
Publicado 1993

The endothelin B (ET(B)) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification

por Cemazar, M, Wilson, I, Prise, V E, Bell, K M, Hill, S A, Tozer, G M
Publicado 2005

Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy

por Cemazar, M, Parkins, C S, Holder, A L, Chaplin, D J, Tozer, G M, Sersa, G
Publicado 2001

An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate

por Williams, L J, Mukherjee, D, Fisher, M, Reyes-Aldasoro, C C, Akerman, S, Kanthou, C, Tozer, G M
Publicado 2014

Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification.

por Tozer, G. M., Prise, V. E., Bell, K. M., Dennis, M. F., Stratford, M. R., Chaplin, D. J.
Publicado 1996

The effects of hyperoxic and hypercarbic gases on tumour blood flow

por Dunn, T J, Braun, R D, Rhemus, W E, Rosner, G L, Secomb, T W, Tozer, G M, Chaplin, D J, Dewhirst, M W
Publicado 1999

Guidelines for the welfare and use of animals in cancer research

por Workman, P, Aboagye, E O, Balkwill, F, Balmain, A, Bruder, G, Chaplin, D J, Double, J A, Everitt, J, Farningham, D A H, Glennie, M J, Kelland, L R, Robinson, V, Stratford, I J, Tozer, G M, Watson, S, Wedge, S R, Eccles, S A
Publicado 2010

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations

por Leach, M O, Brindle, K M, Evelhoch, J L, Griffiths, J R, Horsman, M R, Jackson, A, Jayson, G C, Judson, I R, Knopp, M V, Maxwell, R J, McIntyre, D, Padhani, A R, Price, P, Rathbone, R, Rustin, G J, Tofts, P S, Tozer, G M, Vennart, W, Waterton, J C, Williams, S R, Workman, P
Publicado 2005